FDA & Prescription DrugsMedical MalpracticeAuto AccidentWrongful Death
Products LiabilityPersonal InjuryLabor LawMedical Devices

Napoli Bern Ripka, LLP Blog

Napoli Bern Ripka, LLP Blog
Blog Category:

FDA and Prescription Drugs

    6/30/2008
    Oguz Ozdemir
    Comments (0)

    Ancure

    The Guidant Ancure system is a blood vessel graft that is used to repair an abdominal aneurism. An Aneurysm is a diseased or weakened section of the artery wall that tends to balloon or bulge due to arterial blood pressure (defined by the FDA). It is used instead of the more invasive open surgery in patients who have an abdominal aortic aneurysm and whose anatomy is not suited for the use of the single tube or bifurcated endograft device. The Ancure device, as part as the Ancure Endograft System, was suspended in 2001 by its manufacturer Guidant.  Ancure is a synthetic graft device that is used to repair abdominal aortic aneurysms. The device was suspended due to the fact that Guidant admitted to making false statements to the FDA and not submitting required reports of injuries that occurred in patients who received the Ancure device. Injuries occurring with the Ancure device include leaks, aneurysms, and ruptures which resulted in extended hospitalizations, additional surgeries, and sometimes death.

    In June 2003, Guidant and its subsidiaries agreed to pay fines of $92.4 million after pleading guilty to 10 felonies for not disclosing malfunctions of their Ancure Endograft System. Also, Guidant admitted to failing to report thousands of fatal or life-threatening malfunctions of the device or the highly invasive operations required to correct the damage when the device failed. The complaint suspected that Guidant reported only 172 malfunctions since the product was marketed to the public in 1999. The complaint also alleged that Guidant had 2,628 records of adverse event incidents, including reports that the malfunctions led to 12 deaths and 57 open heart surgeries. In April 2001, the FDA sent a letter to health care professionals who had used Ancure, warning them that “serious problems occurred” with the device. Guidant pleaded guilty to nine counts of introducing a misbranded medical device with the intent to defraud or mislead.

    If you have occurred any of these complications from using the Ancure device, please consult a doctor. In addition, it may be in your best interest to contact a personal injury lawyer at Napoli Bern Ripka who can obtain legal rights on your behalf. They have the legal expertise in dealing with large pharmaceutical companies, insurance giants, and the government. Don’t waste another moment flirting with time, for there may be limitations regarding your case

Comments

There are no comments.

Post a comment

Post a Comment to "Ancure"

To reply to this message, enter your reply in the box labeled "Message", enter your username and password, and hit "Post Message."

Username:

Password:

Register for an account

Message:

 

 

Fill Out Our Free Case Evaluation Form

Quick Contact

Name:

Phone:

Email:

Tell us more:


Napoli Bern LLP
350 5th Avenue
Suite 7413
New York, NY 10118

Toll Free: 877 WTC HERO
Phone: 212 267 3700

Napoli Bern LLP
350 5th Avenue, Suite 7413,
New York, NY 10118

Toll Free: 1 888 LAW IN NY
Phone: 212 267 3700

Locations

New Jersey
1 Greentree Centre
Suite 201
Marlton, NJ 08053

New York
350 5th Avenue,
Suite 7413,
New York, NY 10118

3500 Sunrise Highway,
Suite T-207
Great River, NY 11739

Pennsylvania
2 Penn Center, Suite 200
Philadelphia, PA 19102

Videos

FDA and Prescription Drugs:

Marc Bern discusses the Diet Drug FenPhen on Geraldo

Marc Bern on CourtTV discussing Fen-Phen

Marc Bern is on Geraldo discussing the diet drug Fen-Phen

more